Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RoyalVibe Health is a medical technology company specializing in the development of frequency-based therapy and ultrasound devices for alternative healthcare. The company's core technology utilizes specific resonance frequencies delivered via ultrasound to target various health conditions, including chronic pain, inflammation, and complex diseases like cancer. Their product ecosystem includes the RoyalVibe, CellQuicken, and PetVibe brands, which are designed for non-invasive, at-home use by both human and veterinary patients. The platform is built on the principles of vibrational medicine, aiming to restore cellular health and eliminate pathogens through precise frequency application. RoyalVibe Health operates globally, providing hardware and software solutions that allow users to run automated therapy programs tailored to their specific health needs. The company positions itself as a leader in the field of resonance therapy, focusing on accessible and drug-free treatment alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RoyalVibe Health.